Influence of Patient Position on Attenuation Artifacts Observed in D-SPECT Camera Myocardial Tomoscintigraphy
D-SPECT BIKER
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose is to compare percentages of myocardial segments showing attenuation in patients in forward tilted position (biker position) or 2 conventional positions (dorsal decubitus or semi sitting) at acquisition with D-SPECT camera in myocardial tomoscintigraphy. The hypothesis is that the percentage of myocardial segments with attenuation is significantly lower when acquisitions are made in forward tilted position (biker position). The secondary purpose is to restrict this analysis to 3 cardiac regions most subject to attenuation artifacts (anterior, apical and inferobasal regions).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
August 16, 2016
CompletedFirst Posted
Study publicly available on registry
August 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedAugust 19, 2016
August 1, 2016
1 year
August 16, 2016
August 16, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of myocardial segments classified with attenuation artifact
With infarction aspect but normal contraction kinetics in Gated-SPECT analysis. Left ventricle is divided in 17 segments according to American Heart Association.
day 0
Secondary Outcomes (3)
Percentage of myocardial segments classified with attenuation artifact in anterior region
day 0
Percentage of myocardial segments classified with attenuation artifact in apical region
day 0
Percentage of myocardial segments classified with attenuation artifact in inferobasal region
day 0
Study Arms (3)
forward tilted
EXPERIMENTALPatients with abnormal results at stress myocardial perfusion tomoscintigraphy will undergo a rest tomoscintigraphy. Acquisition will be done in forward tilted position
semi sitting
OTHERPatients with abnormal results at stress myocardial perfusion tomoscintigraphy will undergo a rest tomoscintigraphy. Acquisition will be done in semi sitting
dorsal decubitus
OTHERPatients with abnormal results at stress myocardial perfusion tomoscintigraphy will undergo a rest tomoscintigraphy. Acquisition will be done in dorsal decubitus
Interventions
Rest tomoscintigraphy in forward tilted position
Rest tomoscintigraphy in forward tilted position, followed by a second rest tomoscintigraphy in semi sitting position, after max 30 min
Rest tomoscintigraphy in forward tilted position, followed by a second rest tomoscintigraphy in semi sitting position, after max 30 min
Eligibility Criteria
You may qualify if:
- Affiliation to social security
- Signed informed consent
- Previous clinical examination authorizing patient to undergo tomoscintigraphy
- Patient with abnormal results of stress tomoscintigraphy and needing a rest tomoscintigraphy
- Patient with sinus and regular cardiac rhythm
- Patient with stable clinical status (without signs of unstable cardiac or coronary failure, without uncontrolled hypertension under treatment)
You may not qualify if:
- Women of childbearing potential without effective contraception
- Evolutive pregnancy
- Breastfeeding patient
- Contraindication to tomoscintigraphy
- Patient with history of hypersensibility to tomography radiotracer STAMICIS® or one of components
- Patient in life-and-death emergency
- Patient with history of disorders possibly interfering with contractility
- Patient with normal results of stress tomoscintigraphy
- Person under legal protection or incapable to consent
- Person deprived of liberty by judicial or administrative decision
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Médecine Nucléaire - CHRU de Nancy-Brabois
Vandœuvre-lès-Nancy, France
Study Officials
- PRINCIPAL INVESTIGATOR
Mathieu PERRIN, Dr
Service de Médecine Nucléaire - CHRU de Nancy-Brabois - Vandoeuvre Lès Nancy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 16, 2016
First Posted
August 19, 2016
Study Start
June 1, 2016
Primary Completion
June 1, 2017
Study Completion
June 1, 2017
Last Updated
August 19, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share